Abstract:Objective: To analyze epidemiological and clinical characteristics of laboratory confirmed epidemic cerebrospinal meningitis cases. Methods: Epidemiological and clinical informations and cerebrospinal fluid (CSF) and blood specimens of AMES (acute meningitis/encephalitis syndrome) cases were collected in the six sentinel hospitals from 2007 to 2016. neisseria meningitides (Nm) species and serogroup identification were detected by the methods of real-time fluorescent quantitative polymerase chain reaction (Real-time PCR) and bacterial culture, and epidemiological and clinical characteristics of laboratory confirmed epidemic cerebrospinal meningitis cases were analyzed. Results: 6 809 AMES cases were reported from 2007 to 2016. Total 4 422 cases were detected, and 90 cases were Nm positive. Through the methods of Real-time PCR, bacterial blood culture and CSF culture, the numbers of Nm positive cases were 90, 2 and 1 respectively. Twenty-two Nm cases were identified from 2007 to 2011 (4 cases were ungrouped), which with the highest incidence in serogroup C cases (17/18), and one cases was ungroupable Nm. Nm laboratory confirmed cases (68 cases) were increased dramatically and mainly occurred in serogroup B cases (43/67, 64.2%) from 2012 to 2016, with serogroup C cases highly decreased (5/67, 7.5%) and ungroupable Nm cases increased (13/67, 19.4%) meanwhile. Serogroup W135 and X cases were first detected at 2012 and 2014, and serogroup A remaining a low level which only detected one case at 2013. The morbidity of epidemic cerebrospinal meningitis was occured in the whole year, and mainly in winter and spring. The ratio of Nm laboratory confirmed cases to AMES cases during November to May (3.5%, 67/1 920) was higher than that during June to October (0.9%, 23/2 502) (χ(2)=34.45, P<0.001). Most Nm cases were children, students and farmers, and account for 30.0% (27/90), 31.1% (28/90), 18.9% (17/90), respectively. The majority of Nm cases were under 20 years old (60/90, 66.67%), and serogroup C cases (17/22, 77.3%) mainly occurred in over 12 years old population, while serogroup B (24/43, 55.8%) and ungroupable (6/14) cases mainly occurred in under 12 years old population. The main clinical symptoms of epidemic cerebrospinal meningitis cases were fever (78/90, 86.7%), headache (59/90, 65.6%) and vomiting (51/90, 56.7%). Misdiagnosis rate of admitting diagnosis was up to 87.8% (79/90) for the reason of atypical features in specific symptoms and blood or CSF positive index. The well-healed ratio in correct diagnosed group (7/11) was higher than that in misdiagnosed group (2.5%, 2/79) (χ(2)=40.61, P<0.001). Conclusion: The clinical symptoms of epidemic cerebrospinal meningitis cases were atypical, and the diagnosed sensitivity and accuracy would be improved by enhanced molecular biology detection. The predominant epidemic serogroup of Nm switched from serogroup C to B, and the key work was surveaylance of serogroup transition.

Surveillance on Antibody Level Against Group A and C Epidemic Cerebro-spinal Meningitis Among Healthy Population in Shandong Province in 2003

Investigation on Antibody Level of Epidemic Cerebrospinal Meningitis among Health Population of Ji'nan City in 2003

Epidemiological Analysis for Epidemic Cerebrospinal Meningitis in Shandong Province in 2006/2007

Epidemiological Analysis for Epidemic Cerebrospinal Meningitis in Shandong Province from 2006 to 2008

Epidemiological Characteristic Analysis of Meningococcal Meningitis in Shandong Province,2005/2006

Surveillance and analysis on pathogens of meningococcal meningitis cases in Shandong Province during 2005～2007

Level of Serum Antibody of Neisseria Meningitis (serogroup A and Serogroup C) among the Foreign Laborers in Shenzhen

Serological Epidemiology Investigation of Lyme Disease in Zhejiang Province

[Analysis of Current Epidemiological and Clinical Characteristics for Laboratory Confirmed Epidemic Cerebrospinal Meningitis Cases in Shandong Province, 2007-2016].

Epidemiological Analysis and Control Methods for Epidemic Cerebrospinal Meningitis in Anhui Province During 2004 - 2005

Analysis of First Invasive Meningococcal Disease Death Case Caused by Serogroup C Neisseria Meningitidis in Shandong Province

[Epidemiological and etiological analysis of two infantile cases of serogroup B epidemic cerebrospinal meningitis epidemics in Shandong Province, 2021].

Comparative Analysis on Seroepidemiology of an Aseptic Meningitis Outbreak Caused by ECHO30

[Study on the Bactericidal Antibody Against Neisseria Meningitidis Serogroup C Strains after Immunization with a Divalent Polysaccharide (A Plus C) Vaccine].

[Surveillance of epidemiological features for epidemic cerebrospinal meningitis in China during 1980s]

Clinical Features of Epidemic Cerebrospinal Meningitis of Children in Shanghai Area During 2006 to 2008

Monitoring mumps antibody levels among a healthy people in Shandong province

Epidemiological investigation on an imported W135 epidemic cerebrospinal meningitis case

[Analysis of Neisseria Meningitidis Carriage Characteristics among Healthy Population in Shandong Province from 2008 to 2020].

Immunogenicity of Meningococcal groups ACYW135 polysaccharide vaccine inoculated in healthy population of age 2-59 years old

Surveillance for Creutzfeldt-Jakob Disease in China from 2006 to 2007